pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$ELDNEledon Pharmaceuticals, Inc.

$ELDN
Irvine, CA, USupdated 2mo ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 2: 1
1Phase 2
Phase 2
tegoprubart
Pancreatic Islet Transplant Rejection
CD40 ligand

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipientsenrolling by invitationn=132
  • phase2Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantationcompletedn=127
  • phase2Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplantrecruitingn=48
  • phase2Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)terminatedn=24
🐶 Hiring Signal
No open roles indexed yet — view Eledon Pharmaceuticals, Inc. jobs →

News

  • Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
    After the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape wi…
    biospace · 25d ago
identifiers
ticker
$ELDN
SEC CIK
0001404281
country
US
source
sec_tickers
top tags
Immunology1
mentioned in
1news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 23m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?